GIUNTA, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 10.431
EU - Europa 973
AS - Asia 530
AF - Africa 61
OC - Oceania 28
SA - Sud America 14
Totale 12.037
Nazione #
US - Stati Uniti d'America 10.397
CN - Cina 198
UA - Ucraina 118
IE - Irlanda 117
DE - Germania 110
GB - Regno Unito 104
FR - Francia 98
SE - Svezia 97
IT - Italia 85
IN - India 55
KR - Corea 37
PK - Pakistan 35
NL - Olanda 30
CA - Canada 28
EG - Egitto 28
FI - Finlandia 28
AU - Australia 27
BE - Belgio 27
HK - Hong Kong 26
ID - Indonesia 24
TR - Turchia 24
ES - Italia 22
CH - Svizzera 18
JP - Giappone 18
TW - Taiwan 18
HU - Ungheria 17
PL - Polonia 17
VN - Vietnam 16
RU - Federazione Russa 15
IR - Iran 13
PH - Filippine 13
RO - Romania 12
NG - Nigeria 10
EE - Estonia 9
PT - Portogallo 9
ZA - Sudafrica 9
GR - Grecia 8
IL - Israele 8
IQ - Iraq 7
SG - Singapore 6
UZ - Uzbekistan 6
CZ - Repubblica Ceca 5
DK - Danimarca 5
MA - Marocco 5
TH - Thailandia 5
AT - Austria 4
BJ - Benin 4
BR - Brasile 4
HR - Croazia 4
KG - Kirghizistan 4
NO - Norvegia 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
KW - Kuwait 3
LT - Lituania 3
MX - Messico 3
MY - Malesia 3
PE - Perù 3
CO - Colombia 2
ET - Etiopia 2
LB - Libano 2
RS - Serbia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AR - Argentina 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
GP - Guadalupe 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MG - Madagascar 1
NA - Namibia 1
NZ - Nuova Zelanda 1
OM - Oman 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 12.037
Città #
Wilmington 3.078
Houston 2.791
Woodbridge 2.331
Fairfield 408
Ashburn 241
Chandler 236
Cambridge 168
Ann Arbor 167
Seattle 155
Dearborn 103
Dublin 93
Medford 86
Jacksonville 85
Beijing 60
New York 52
Lawrence 39
Rome 38
Zhengzhou 30
Redwood City 28
San Diego 25
Shanghai 23
Jönköping 20
London 15
Duncan 13
Hefei 13
Jakarta 13
Menlo Park 13
Brussels 12
Norwalk 12
Milan 11
Stockholm 11
Budapest 10
Central 10
Hangzhou 10
Nanjing 10
Salcedo 10
Lahore 9
Ottawa 9
Seoul 9
Cairo 8
Kraków 8
Kunming 8
Lagos 8
Palo Alto 8
Tokyo 8
Dong Ket 7
Esslingen am Neckar 7
Tallinn 7
Utrecht 7
Bucharest 6
Islamabad 6
New Delhi 6
Taipei 6
Toronto 6
Hanoi 5
Istanbul 5
Jinan 5
Mülheim 5
Phoenix 5
Saint Louis 5
Alexandria 4
Augusta 4
Boardman 4
Brisbane 4
Central District 4
Cotonou 4
Düsseldorf 4
Geneva 4
Huskvarna 4
Hyderabad 4
Johannesburg 4
Lublin 4
Madrid 4
Melbourne 4
Mountain View 4
Redmond 4
Saint Petersburg 4
San Francisco 4
San Mateo 4
Sonīpat 4
Sydney 4
Vilvoorde 4
Adana 3
Auburn Hills 3
Bankeryd 3
Barcelona 3
Binh Tan 3
Center 3
Copenhagen 3
Creede 3
Córdoba 3
Delhi 3
Detroit 3
Jerusalem 3
Kahramanmaras 3
Kolkata 3
Kuwait City 3
Lappeenranta 3
Lima 3
Los Angeles 3
Totale 10.725
Nome #
European S3-guidelines on the systemic treatment of psoriasis vulgaris 1.339
Loss of CRABP-II Characterizes Human Skin Poorly Differentiated Squamous Cell Carcinomas and Favors DMBA/TPA-Induced Carcinogenesis 642
Emergence of antinuclear antibodies in psoriatic patients treated with infliximab: personal experience and literature review 401
Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study 397
New topical treatments for psoriasis 397
Resolution with rituximab of localized scleroderma occurring during etanercept treatment in a patient with rheumatoid arthritis 381
Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management 381
Resolution of idiopathic recurrent pericarditis in a psoriatic arthritis patient treated with etanercept 379
Continuous treatment of plaque-type psoriasis with etanercept: An observational long-term experience 375
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 374
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 361
Morbid obesity and psoriasis: Disease remission after laparoscopic sleeve gastrectomy 361
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 351
Remission of psoriatic arthritis after etanercept discontinuation: analysis of patients' clinical characteristics leading to disease relapse 347
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 343
Dermatitis artefacta in sporadic sclerodermoid hepatitis C virus-associated porphyria cutanea tarda 331
Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy 326
Long-lasting remission of pemphigus vulgaris treated with rituximab 314
From patients’ needs to treatment outcomes in psoriasis: Results from the ‘pSORRIDI’ experience 310
Rapid, persistent, and simultaneous remission of urticaria and severe atopic dermatitis after treatment with omalizumab 302
Treatment of Hailey-Hailey disease with topical calcitriol 289
Histopathology of the skin in rheumatic diseases 287
Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry 287
null 287
Early detection of IgH monoclonal rearrangenent in follicular spicules of the nose preceding multiple myeloma diagnosis. Case report and review of the literature 286
Etanercept biosimilar SB4 in the treatment of plaque-type psoriasis and psoriatic arthritis: a single-center, observational, retrospective, real-life study 270
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 261
Association between psoriasis and periodontitis, and efficacy of anti-TNF-α therapy: a case series 254
A case of generalized pustular psoriasis and arthritis treated with ixekizumab 253
Long-term treatment with etanercept monotherapy in a hemodialyzed patient with moderate-to-severe plaque-type psoriasis and psoriatic arthritis 236
Apremilast efficacy and safety in a psoriatic arthritis patient affected by HIV and HBV virus infections 221
The economic impact of biosimilars in Italy: a scenario analysis 204
Therapeutic monitoring of male genital lichen sclerosus: usefulness of reflectance confocal microscopy 200
Long-term safety and efficacy of secukinumab in patients with psoriasis and major psychiatric disorders: a case series 144
The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximab 129
Depressive symptoms and insecure attachment predict disability and quality of life in psoriasis independently from disease severity 97
Efficacy and safety of ixekizumab in psoriatic arthritis: a retrospective, single-centre, observational study in a real-life clinical setting 63
Ixekizumab in nail psoriasis 60
Connective tissue nevus in Marfan syndrome successfully treated with intralesional steroid injections 49
High expression of cellular retinol binding protein-1 in lung adenocarcinoma is associated with poor prognosis 13
Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress 9
Combination therapy with etanercept in psoriasis: Retrospective analysis of efficacy and safety outcomes from real-life practice 7
Totale 12.318
Categoria #
all - tutte 23.212
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.212


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019670 0 0 0 0 0 0 0 0 0 0 303 367
2019/20203.512 279 271 254 316 324 373 344 304 321 274 209 243
2020/20212.384 237 248 230 273 285 271 282 242 87 100 84 45
2021/2022688 28 88 50 66 22 52 49 44 55 47 60 127
2022/2023768 64 75 37 93 61 112 66 63 91 23 39 44
2023/2024407 48 26 28 31 39 99 49 52 12 22 1 0
Totale 12.318